Compositions and methods for treatment of intracellular damage and bacterial infection
AssigneeBioincept, LLC
InventorEytan R. Barnea
Life of this patent
Estimating the term…
Loading patent…
AssigneeBioincept, LLC
InventorEytan R. Barnea
Estimating the term…
Pre-implantation factor (PIF) may be used to treat intracellular damage. Aspects of the invention are directed to a method of treating intracellular damage comprising administering PIF to a subject in need thereof. Some aspects may be directed to methods of increasing cytokine secretion in response to intracellular damage comprising administering PIF to a subject in need thereof. The intracellular damage may be a result of a disease such as Listeria monocytogenes infection, malaria, Lyme disease, cardiovascular disease, duodenal peptic ulcer, atherosclerosis, peritonitis or tuberculosis. In some aspects, a method of treating tuberculosis is disclosed, comprising administering PIF to a subject in need thereof. In some aspects, a method of treating atherosclerosis is disclosed, comprising administering PIF to a subject in need thereof. In some aspects, a method of treating peritonitis is disclosed, comprising administering PIF to a subject in need thereof.
A method of treating atherosclerosis comprising administering to a subject in need thereof a therapeutically effective amount of a PIF peptide selected from SEQ ID NO:
A method of reducing atherosclerotic plaque and/or inhibiting atherosclerotic lesion development in a subject, comprising administering to the subject a therapeutically effective amount of a PIF peptide selected from SEQ ID NO:
A method of decreasing recruitment to and/or retention of monocytes within an atherosclerotic lesion in a subject, comprising administering to the subject a therapeutically effective amount of a PIF peptide selected from SEQ ID NO:
Dependencies are inferred from the claim text.